RCP Therapeutics Ltd acquires the IP and assets of Telemolecular Corporation
New operational headquarters situated in London, UK
RCP Therapeutics has identified a series of product candidates and has pilot launched its lead product candidate, Bimene, a novel cosmeceutical topical product, utilising its nano particle delivery platform acquired via licenses from universities and US based research institutions.
New management, appointed to run Telomolecular Corporation in May 2008, set in motion a business strategy culminating in the formation of RCP Therapeutics. Operationally, the Company will retain its research laboratory in Sacramento, securing the facilities status as RCP Therapeutics’ primary research and development site. Furthermore, the Company’s plans to expand the Californian operation and increase the number of scientists and staff employed at the site. Commercialisation of RCP Therapeutics’ cosmeceutical products in the US will be co-ordinated from the same location.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.